BFRI

Biofrontera Inc.

4 catalysts on file

BFRI

Biofrontera Inc.

Phase 3 Confirmed

Ameluz

mild to moderate actinic keratoses (AKs)

193d ago Feb 9, 2026

SEC 8-K verified 2mo ago

BFRI

Biofrontera Inc.

Phase 2 Confirmed

Ameluz

moderate to severe acne vulgaris (AV)

99d ago May 14, 2026

SEC 8-K verified 2mo ago

BFRI

Biofrontera Inc.

PDUFA Confirmed

Ameluz

superficial basal cell carcinoma (sBCC)

T-minus 38 days Sep 28, 2026

SEC 8-K verified 2mo ago

BFRI

Biofrontera Inc.

CRL AI-extracted

Ameluz

superficial basal cell carcinoma (sBCC)

Date TBD Date TBD

SEC 8-K verified 2mo ago